Yahoo Italia Ricerca nel Web

Risultati di ricerca

  1. 4 giorni fa · Licensing agreement reached for contrast agent for use in patients with prostate cancer. A late phase 3 trial evaluating the agent is underway at several clinics in Europe. "The 2 agreements mark the start of a new product line," said Sanochemia Managing Director Thomas Erkinger in a news release. Sanochemia Pharmazeutika announced that it has ...

  2. 2 giorni fa · Novartis’ $3 billion MorphoSys boondoggle. By Adam Feuerstein. Reprints. This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up ...

  3. 1 giorno fa · Bookmark. Mark Steel has shared the triumphant news he is now cancer free as he reveals doctors "saved his life". The comedian and BBC radio star, 63, wrote a candid column for The Mirror as he ...

  4. 5 giorni fa · In 2015. he coauthored a US study which found that 66% of participants thought that everything causes cancer, and 58% automatically associated cancer with death.

  5. 4 giorni fa · Cancer patient who won $1.3 billion lottery said he would find a good doctor for himself—’I don’t want to die yet,’ he prayed BY Claire Rush and The Associated Press 0 minutes ago

  6. 5 giorni fa · Sinha and colleagues present PERCEPTION, a precision oncology computational pipeline that can predict the response and resistance of patients by analyzing single-cell transcriptomic data from ...

  7. 3 giorni fa · Ovarian borderline tumors, also known as low malignant potential (LMP) ovarian tumors, do not cause an increase in CA125 levels and are not identifiable with an ultrasound. The typical symptoms of an LMP tumor can include abdominal distension or pelvic pain. Particularly large masses tend to be benign or borderline.